These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 19362962
1. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia. Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ, Rajkumar SV. Clin Lymphoma Myeloma; 2009 Mar; 9(1):17-8. PubMed ID: 19362962 [Abstract] [Full Text] [Related]
2. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM). Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV. Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195 [Abstract] [Full Text] [Related]
3. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia. McMaster ML, Kristinsson SY, Turesson I, Björkholm M, Landgren O. Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963 [Abstract] [Full Text] [Related]
4. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia. Kyle RA, Therneau TM, Dispenzieri A, Kumar S, Benson JT, Larson DR, Melton LJ, Rajkumar SV. Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):184-6. PubMed ID: 23490989 [Abstract] [Full Text] [Related]
5. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia. Mailankody S, Landgren O. Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465 [Abstract] [Full Text] [Related]
6. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification. Paiva B, Montes MC, García-Sanz R, Ocio EM, Alonso J, de Las Heras N, Escalante F, Cuello R, de Coca AG, Galende J, Hernández J, Sierra M, Martin A, Pardal E, Bárez A, Alonso J, Suarez L, González-López TJ, Perez JJ, Orfao A, Vidríales MB, San Miguel JF. Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227 [Abstract] [Full Text] [Related]
11. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia. Gertz MA, Kyle RA, Noel P. J Clin Oncol; 1993 May 15; 11(5):914-20. PubMed ID: 8487054 [Abstract] [Full Text] [Related]
12. Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression. Andrade-Campos M, Murillo-Flórez I, García-Sanz R, Giraldo P. Clin Chem Lab Med; 2017 Aug 28; 55(10):1598-1604. PubMed ID: 28284031 [Abstract] [Full Text] [Related]
13. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Pilarski LM, Andrews EJ, Serra HM, Ledbetter JA, Ruether BA, Mant MJ. Am J Hematol; 1989 Feb 28; 30(2):53-60. PubMed ID: 2536515 [Abstract] [Full Text] [Related]
14. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy. Greco A, Tedeschi A, Varettoni M, Nichelatti M, Paris L, Ricci F, Vismara E, Morra E. Clin Lymphoma Myeloma Leuk; 2011 Feb 28; 11(1):77-9. PubMed ID: 21454196 [Abstract] [Full Text] [Related]
15. Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies. Morra E, Cesana C, Klersy C, Barbarano L, Miqueleiz S, Varettoni M, Lucchesini C, Ricci F, Lazzarino M. Clin Lymphoma; 2005 Mar 28; 5(4):265-9. PubMed ID: 15794862 [Abstract] [Full Text] [Related]
16. Clinicopathological correlates of IgM paraproteinemias. Owen RG, Parapia LA, Higginson J, Misbah SA, Child JA, Morgan GJ, Jack AS. Clin Lymphoma; 2000 Jun 28; 1(1):39-43; discussion 44-5. PubMed ID: 11707811 [Abstract] [Full Text] [Related]
17. Progression in smoldering Waldenstrom macroglobulinemia: long-term results. Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Melton LJ, Rajkumar SV. Blood; 2012 May 10; 119(19):4462-6. PubMed ID: 22451426 [Abstract] [Full Text] [Related]
18. Monoclonal gammopathy: natural history studied with a retrospective approach. Steingrimsdottir H, Haraldsdottir V, Olafsson I, Gudnason V, Ogmundsdottir HM. Haematologica; 2007 Aug 10; 92(8):1131-4. PubMed ID: 17650445 [Abstract] [Full Text] [Related]
19. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Blade J, Lopez-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar JL, Vives-Corrons JL, Montserrat E. Br J Haematol; 1992 Jul 10; 81(3):391-4. PubMed ID: 1390212 [Abstract] [Full Text] [Related]
20. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients. Cao XX, Meng Q, Mao YY, Su W, Zhen JF, Shen KN, Zhang CL, Huang XF, Duan MH, Zhang W, Zhu TN, Cai HC, Chen M, Zhou DB, Li J. Leuk Res; 2016 Jul 10; 46():85-8. PubMed ID: 27232065 [Abstract] [Full Text] [Related] Page: [Next] [New Search]